Akero Therapeutics, Inc. Current Assets
Akero Therapeutics, Inc. had Current Assets of $754.53 million as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2025-11-07
- 2025-09-30: Assets, Current $754.53M.
- 2025-06-30: Assets, Current $764.60M.
- 2025-03-31: Assets, Current $713.15M.
- 2024-12-31: Assets, Current $770.38M.
| Period end | Assets, Current |
|---|---|
| 2025-09-30 | $754.53M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $764.60M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $713.15M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $770.38M 10-Q · filed 2025-11-07 |
| 2024-09-30 | $746.89M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $776.01M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $911.28M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $559.96M 10-K · filed 2025-02-28 |
| 2023-09-30 | $575.98M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $643.20M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $347.49M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $355.17M 10-K · filed 2024-02-29 |
| 2022-09-30 | $377.95M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $184.15M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $167.93M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $193.58M 10-K · filed 2023-03-17 |
| 2021-09-30 | $221.81M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $236.22M 10-Q · filed 2021-08-13 |
| 2021-03-31 | $255.78M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $271.35M 10-K · filed 2022-02-25 |
| 2020-09-30 | $298.03M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $113.19M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $126.22M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $138.05M 10-K · filed 2021-03-16 |
| 2019-09-30 | $150.07M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $163.11M 10-Q · filed 2019-08-12 |
| 2018-12-31 | $77.13M 10-K · filed 2020-03-16 |